NCT06023758 2024-05-10
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Phase 2 Recruiting
Clinical Trials
1 trialsInterventional × HER2-positive Locally Advanced Resectable Gastric Cancer × Gastrointestinal × Clear all